Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 7235 | 1314 | 26.6 | 76% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2272 | 4206 | BIOANALYSIS//LC NMR//DRIED BLOOD SPOT DBS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | BIOANALYSIS | Journal | 18 | 12% | 11% | 139 |
| 2 | BIOANALYT METAB PHARMACOKINET | Address | 10 | 73% | 1% | 8 |
| 3 | CASSETTE ANALYSIS | Author keyword | 9 | 83% | 0% | 5 |
| 4 | CORE TECHNOL AREA ANALYT UNIT | Address | 9 | 83% | 0% | 5 |
| 5 | TURBULENT FLOW CHROMATOGRAPHY | Author keyword | 6 | 34% | 1% | 14 |
| 6 | ION SUPPRESSION | Author keyword | 6 | 23% | 2% | 21 |
| 7 | BIOANALYT CORE GRP | Address | 5 | 54% | 1% | 7 |
| 8 | PARALLEL SAMPLE PROCESSING | Author keyword | 4 | 75% | 0% | 3 |
| 9 | PHARMACOKINETIC SCREENING | Author keyword | 4 | 75% | 0% | 3 |
| 10 | R46W | Address | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PARALLEL PURIFICATION | 38 | 93% | 1% | 14 |
| 2 | BIOANALYSIS | 21 | 20% | 7% | 94 |
| 3 | ION SUPPRESSION | 20 | 29% | 4% | 57 |
| 4 | 96 WELL FORMAT | 19 | 53% | 2% | 25 |
| 5 | TURBULENT FLOW CHROMATOGRAPHY | 18 | 45% | 2% | 30 |
| 6 | ULTRA FAST GRADIENT | 18 | 89% | 1% | 8 |
| 7 | DRUG DISCOVERY COMPOUNDS | 17 | 75% | 1% | 12 |
| 8 | HIGH THROUGHPUT PURIFICATION | 16 | 53% | 2% | 21 |
| 9 | VALIDATION GROUP WORKSHOP | 15 | 67% | 1% | 14 |
| 10 | DISCOVERY COMPOUNDS | 15 | 88% | 1% | 7 |
Journals |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOANALYSIS | 18 | 12% | 11% | 139 |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Matrix effects: The Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry | 2005 | 498 | 36 | 56% |
| AN OVERVIEW OF MATRIX EFFECTS IN LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY | 2011 | 153 | 130 | 43% |
| Ion suppression in mass spectrometry | 2003 | 696 | 13 | 77% |
| Signal suppression/enhancement in high-performance liquid chromatography tandem mass spectrometry | 2010 | 168 | 75 | 51% |
| Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS | 2007 | 238 | 76 | 64% |
| Key elements of bioanalytical method validation for small molecules | 2007 | 133 | 1 | 100% |
| Ion suppression; A critical review on causes, evaluation, prevention and applications | 2013 | 36 | 82 | 39% |
| Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect | 2014 | 12 | 111 | 35% |
| High-throughput quantitative bioanalysis by LC/MS/MS | 2000 | 229 | 47 | 81% |
| Validation of bioanalytical LC-MS/MS assays: Evaluation of matrix effects | 2009 | 223 | 75 | 33% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOANALYT METAB PHARMACOKINET | 10 | 73% | 0.6% | 8 |
| 2 | CORE TECHNOL AREA ANALYT UNIT | 9 | 83% | 0.4% | 5 |
| 3 | BIOANALYT CORE GRP | 5 | 54% | 0.5% | 7 |
| 4 | R46W | 4 | 75% | 0.2% | 3 |
| 5 | BIOANALYT DISCOVERY ANALYT SCI | 3 | 20% | 1.0% | 13 |
| 6 | MED CHEMDRUG METAB SECT | 2 | 67% | 0.2% | 2 |
| 7 | DRUG METAB SECT | 2 | 50% | 0.2% | 3 |
| 8 | EXPLORATORY DRUG METAB | 2 | 33% | 0.4% | 5 |
| 9 | BIOANAL DRUG METAB | 2 | 14% | 0.8% | 11 |
| 10 | BIOANAL IMMUNOL | 1 | 100% | 0.2% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000172222 | REACTIVE METABOLITE//MASS DEFECT FILTER//TIENILIC ACID |
| 2 | 0.0000133954 | MICROEXTRACTION IN PACKED SYRINGE//MICROEXTRACTION BY PACKED SORBENT//POLYSTYRENE SORBENT |
| 3 | 0.0000127578 | DRIED BLOOD SPOT DBS//BIOANALYSIS//DRIED BLOOD SPOTS |
| 4 | 0.0000119299 | ATMOSPHERIC PRESSURE PHOTOIONIZATION//APLI//ATMOSPHERIC PRESSURE LASER IONIZATION |
| 5 | 0.0000117324 | DISCOVERY ANALYT CHEM CHEM TECHNOL//LC MS TECHNOL DEV//SHANGHAI MASS SPE OMETRY |
| 6 | 0.0000117250 | OSI 420//OSI 774//CAKI 1 RENAL CELL CARCINOMA |
| 7 | 0.0000108779 | SISCAPA//PSAQ//BIOMARKER VERIFICATION |
| 8 | 0.0000104982 | ACCURACY PROFILE//ANALYTICAL METHOD TRANSFER//LERMDV |
| 9 | 0.0000098269 | SYSTEMATIC TOXICOLOGICAL ANALYSIS//GENERAL UNKNOWN SCREENING//NORTILIDINE |
| 10 | 0.0000097124 | RESTRICTED ACCESS MEDIA//MIXED FUNCTIONAL PHASE//ISRP COLUMN |